Lt8.5

Luteolin

Luteolin

A potent anti-inflammatory flavonoid found in celery and peppers that supports brain health, reduces inflammation, and may help with allergies and mast cell disorders.

immunitymentalflavonoidanti-inflammatoryneuroprotectionmast-cell
Last reviewed: February 1, 2025
8.5/10
40+ studies
Evidence
high
Safety
100-400mg daily
Dose
4-12 weeks
Time to Effect
Luteolin extract or Luteolin-quercetin complex
Best Form

Luteolin is a flavonoid found in celery, peppers, parsley, and chamomile. It's one of the most potent natural anti-inflammatory compounds, particularly notable for its ability to cross the blood-brain barrier and reduce neuroinflammation. It inhibits mast cell activation, making it useful for allergies and histamine-related conditions. Research also suggests neuroprotective effects and potential benefits for autism spectrum disorders.

Mechanisms of Action

🔥
Anti-Inflammatory

Potent inhibitor of inflammatory pathways

🛡️
Mast Cell Stabilization

Prevents histamine release

🧠
Neuroprotection

Crosses BBB to protect brain cells

Recommended Dose

100-400mg daily

50mg600mg

Loading: Not established

Optimal Timing

  • With meals
  • Can divide into 2-3 doses

Take with food

Best Form

Luteolin extract or Luteolin-quercetin complex

Alternatives: Luteolin with palmitoylethanolamide (PEA), Chamomile extract (contains luteolin)

Pure luteolin has limited bioavailability. Lipid-based or complexed forms may absorb better.

Duration

Minimum: 4 weeks

Optimal: 12 weeks

Cycling: Not required

Note: Better absorbed with fat. Often combined with quercetin or rutin for enhanced effects.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

🔥
Reduced Inflammation

Lower inflammatory markers systemically

2-4 weeks
65% of users notice thispositive
🌸
Allergy Relief

Reduced allergic symptoms and histamine reactions

2-4 weeks
60% of users notice thispositive
🧠
Brain Health

Neuroprotective and cognitive support

4-8 weeks
50% of users notice thispositive
High SafetyMax safe dose: Not established; 400mg/day commonly used
🟡
Those with mast cell activation

May help reduce symptoms; start low

🟡
Those with allergies

Natural antihistamine properties

Who Should NOT Take This

  • Known allergy or hypersensitivity to Luteolin or related compounds

Drug Interactions

CYP3A4 substratesmild

May inhibit CYP3A4 enzyme

Possible Side Effects

GI upsetrare

Tip: Take with food

Warnings

  • Limited human clinical trials
  • May affect drug metabolism (CYP3A4)
  • Bioavailability is variable

Top studies from 40+ peer-reviewed papers

systematic-review
DOI

Gonfa YH et al. • Zeitschrift fur Naturforschung. C, Journal of biosciences (2025)

“The primary focus of this systematic review is to analyze the current state of the literature regarding treating liver ailments using extracts from medicinal plants, examining their phytochemical composition, and addressing associated safety considerations.© 2024 Walter de Gruyter GmbH, Berlin/Boston.”
Key Findings:
  • The application of natural products derived from medicinal plants in treating liver injuries is rooted in their efficacy, cost-effectiveness, and safety profile, contributing to their popularity.
  • Many studies, encompassing in vitro, in vivo, preclinical, and clinical investigations, have demonstrated that the extracts of medicinal plants mitigate chemical-induced liver damage using animal models.
  • However, intensive research efforts regarding the safety, regulatory standard, and quality control issues for using medicinal plants as hepatoprotective agents remain the strong task of scholars.
systematic-reviewn=17
DOI

Gorenshtein A et al. • Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2024)

“This systematic-review examined the effects of Luteolin.”
Key Findings:
  • Noninvasive brain stimulation and hyperbaric oxygen therapy showed promising results in the treatment of brain fog symptoms caused by long-COVID, with improved perfusion and cortical excitability.
  • Furthermore, both rehabilitation strategies and PEA-LUT administration have been associated with improvements in symptoms of brain fog.
  • Future studies should explore combinations of interventions and include longer follow-up periods to assess the long-term effects of these treatments.© 2024.
meta-analysisn=896
DOI

Wu X et al. • Medicine (2024)

“These results provided scientific basis for the clinical use of Danhong injection for the treatment of IPF, and provided a new direction to explore the potential mechanism of action of Danhong injection.”
Key Findings:
  • These results provided scientific basis for the clinical use of Danhong injection for the treatment of IPF, and provided a new direction to explore the potential mechanism of action of Danhong injection.
  • Published in Medicine (2024)
  • Further research warranted to confirm findings
systematic-reviewn=1140
DOI

Weng J et al. • Annals of medicine (2023)

“The results of a meta-analysis of 12 RCTs indicate that TCM intervention can improve the clinical treatment efficacy of CAG.”
Key Findings:
  • The results of a meta-analysis of 12 RCTs indicate that TCM intervention can improve the clinical treatment efficacy of CAG.
  • NPAs identified seven hub TCM and 13 target genes associated with their actions, while bioinformatics analysis identified two DEGs between normal and CAG gastric tissues.
  • Finally, molecular docking was employed to reveal the mechanism of action of the active molecules in TCM on the DEGs.
  • These findings not only reveal the mechanisms of action of the active components of the TCMs, but also provide support for the development of new drugs, ultimately blocking the progression from chronic gastritis to gastric cancer.
meta-analysisn=1633
DOI

Qu P et al. • Medicine (2023)

“GSZD could be a satisfactory complementary and alternative therapy for treating gouty arthritis.”
Key Findings:
  • GSZD could be a satisfactory complementary and alternative therapy for treating gouty arthritis.
  • However, it should be verified by further studies.
  • Future research on gouty arthritis could be conducted from the active components including beta-sitosterol and sitosterol, the targets including TNF-1, IL1B, and ESR1, and the signaling pathways including IL-17 and HIF-1.
40
Total Studies
8.9/10
Avg Quality
17-6,464
Sample Size Range
2013-2025
Research Span

Study Type Distribution

Systematic Review
18
RCT
12
Meta-Analysis
7
Animal
1
Review
1
Crossover
1

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.